
Q&A: C Ventures’ Ben Cheng

Ben Cheng, a managing partner of C Ventures, mixes lifestyle trends and corporate VC as he helps Adrian Cheng, scion of Hong Kong’s New World Development, usher the family empire into a digital future
Q: Can you describe your approach to investment? A: Our strategy is very simple. We don’t see ourselves as a financial investor – we are strategic. Whatever we invest in, we have to have an angle...
Latest News
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.